Cost of stroke from a tertiary center in northwest India

Pandian, JeyarajD; Singh, Yashpal; Toor, Gagan; Badyal, Dinesh; Kaur, Prameet; Kaur, Raminder; Kwatra, Gagandeep

doi:10.4103/0028-3886.125270

Cited by 19 publications

(25 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The common measure of OOPP was expenditure for per hospital stay or inpatient care or hospitalization cost per household member [ 24 , 25 , 34 , 35 , 38 ] while cost subdivided in terms of indirect cost, direct cost, non-medical cost or was calculated altogether [ 42 , 43 ]. OOPP as the proportion of total household spending [ 34 , 38 ] or perceived financial hardship by caretakers was also studied [ 41 ].…”

Section: Resultsmentioning

confidence: 99%

The economic impact of non-communicable diseases among households in South Asia and their coping strategy: A systematic review

et al. 2018

View full text Add to dashboard Cite

BackgroundOut of pocket payment (OOPP), is the major health financing mechanism in South Asia region. With the rising burden of non-communicable diseases (NCDs), the region is facing a high financial burden. However, the extent and nature of economic impact caused by treatment and management of NCDs at the household level is yet unknown.MethodWe conducted a systematic review using Medline and Embase databases. Only peer-reviewed quantitative studies published between January 2000 to December 2016 assessing OOPP or catastrophic health expenditure or impoverishment or financial coping strategy due to at least one of the four major NCDs—cardiovascular diseases(CVDs), diabetes, cancer, chronic respiratory disease in South Asia region was included in the review. The review is registered in PROSPERO no: CRD42017059345.ResultsA total of 21 studies (of 2693 records identified) met the inclusion criteria. The economic impact was most frequently studied in CVDs and in terms of OOPP. The studies collectively indicated high OOPP, higher likelihood of catastrophic expenditure and impoverishment for inpatient care for these major NCDs which was visible in all income levels. Borrowing and selling off assets were the most common forms of coping strategies adopted and varied inconsistently between urban and rural households. The true extent of the economic impact, however, remains difficult to determine due to methodological heterogeneity regarding outcomes reported and measures employed for calculation of OOPP, catastrophic expenditure, and impoverishment across these four major NCDs and between nations.ConclusionThe economic impact due to treatment and management of CVDs, diabetes, cancer and chronic respiratory diseases among households in South Asia seems dire. Given the lack of sufficient evidence the review stresses the need for further research in the region to develop evidence-informed nationally tailored prepayment mechanisms covering NCDs to reduce economic vulnerability and standardization of tools measuring the economic impact for generating comparable estimates.

show abstract

Section: Resultsmentioning

confidence: 99%

The economic impact of non-communicable diseases among households in South Asia and their coping strategy: A systematic review

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Although eight papers met the selection criteria, these included a systematic review (Gheorghe et al, 2018), with only one study relevant to our scoping review (Huffman et al, 2011). A decision was made to exclude the systematic review and include only the relevant study (Huffman et al, 2011), resulting in eight studies being included in the scoping review (Bahuguna et al, 2020; Basu et al, 2015; Chhabra et al, 2019; Gopi et al, 2017; Huffman et al, 2011; Kwatra et al, 2013; Marfatia et al, 2014; Singla & Singla, 2016). Details of the records excluded following full-text screening (with related reasons) are presented in Table S5.…”

Section: Resultsmentioning

confidence: 99%

“…The included studies were set in broad and specific geographical locations, ranging from the whole of India (n = 1 [Basu et al, 2015]) to specific states or regions-Delhi National Capital Region (n = 1 [Singla & Singla, 2016]) and Punjab, Haryana, Tamil Nadu, Odisha, Himachal Pradesh and Kerala (n = 1 [Bahuguna et al, 2020])-and cities, that is Guntur (n = 1 [Gopi et al, 2017]), Gurgaon, Mumbai and Bengaluru (n = 1 [Marfatia et al, 2014]), Trivandrum (n = 1 [Huffman et al, 2011]), Ludhiana (n = 1 [Kwatra et al, 2013]) and an unspecified location in Punjab (n = 1 [Chhabra et al, 2019]).…”

Section: Overall Summary Of Included Studiesmentioning

confidence: 99%

“…Within the six months post admission, the mean of the total cost per patient ranged from `19,428.86 (n = 130), as measured in a neurology department of a tertiary care government hospital in an unspecified location in Punjab (Chhabra et al, 2019), to `118,040.15 (n = 189; 95% confidence interval (CI): `106,270.11 to `129,698.91) in a private tertiary care centre (stroke unit and neurology clinic) in Ludhiana (Kwatra et al, 2013) (Table 1).…”

Section: Total Costsmentioning

confidence: 99%

See 1 more Smart Citation

Costs of Hospital Care for Strokes in India: A Scoping Review

Benedetto

Cadilhac

Spencer

et al. 2022

The Indian Economic Journal

View full text Add to dashboard Cite

The incidence of stroke in India is one of the largest worldwide. With this scoping review, we assessed the evidence on the costs of stroke, which is essential to evaluate whether stroke care interventions are cost-effective. We adopted a healthcare sector and broader societal perspective and searched electronic databases for records including stroke cost estimates (up to 2020). Following deduplication and screening of 2,510 records, we extracted the data (converted into 2020 Indian rupees [INR]) and assessed the quality of eight eligible studies. These studies, published between 2011 and 2020, covered the whole of India and specific localities and were: cost-of-illness studies (n = 3); economic evaluations (n = 2); cross-sectional costing study (n = 1); simulated costing study (n = 1); and policy/clinical review (n = 1). Among the extracted estimates, the mean total costs of stroke care per patient for the period up to six months post admission ranged from ₹19,428.86 in a government hospital in Punjab to ₹118,040.15 in a private tertiary care centre in Ludhiana. The median total out-of-pocket (OOP) payments for cardiovascular disease-related expenditures ranged from ₹18,148.88 to ₹68,464.39 across different income groups. Despite methodological limitations, the data from our scoping review will help in designing economic evaluations of stroke care interventions in India. JEL Codes: C18, C80, D61, I15, I19

show abstract

“…Results of this review will be reported in line with the PRISMA 2009 checklist. 28 The overall quality of evidence on outcomes will be presented using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach, 29 which involves consideration of within-study risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias. We will rate overall quality of evidence at four levels: high, moderate, low and very low.…”

Section: Methods and Analysismentioning

confidence: 99%

Cost-effectiveness of interventions to control cardiovascular diseases and type 2 diabetes mellitus in South Asia: protocol for a systematic review

et al. 2015

View full text Add to dashboard Cite

IntroductionWhile a number of strategies are being implemented to control cardiovascular diseases (CVDs) and type 2 diabetes mellitus (T2DM), the cost-effectiveness of these in the South Asian context has not been systematically evaluated. We aim to systematically review the economic (cost-effectiveness) evidence available on the individual-, group- and population-level interventions for control of CVD and T2DM in South Asia.Methods and analysisThis review will consider all relevant economic evaluations, either conducted alongside randomised controlled trials or based on decision modelling estimates. These studies must include participants at risk of developing CVD/T2DM or with established disease in one or more of the South Asian countries (India, Bangladesh, Pakistan, Sri Lanka, Nepal, Maldives, Bhutan and Afghanistan). We will identify relevant papers by systematically searching all major databases and registries. Selected articles will be screened by two independent researchers. Methodological quality of the studies will be assessed using a modified Drummond and a Phillips checklist. Cochrane guidelines will be followed for bias assessment in the effectiveness studies.ResultsResults will be presented in line with the PRISMA (Preferred Reporting Items for Systematic review and Meta-analysis) checklist, and overall quality of evidence will be presented as per the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach.Ethics and disseminationThe study has received ethics approval from the All India Institute of Medical Sciences, New Delhi, India. The results of this review will provide policy-relevant recommendations for the uptake of cost-effectiveness evidence in prioritising decisions on essential chronic disease care packages for South Asia.Study registration numberPROSPERO CRD42013006479.

show abstract

Cost of stroke from a tertiary center in northwest India

Abstract: Direct medical cost or acute care of stroke accounted for a major component of cost of stroke. Poor outcome, length of hospital stay, and higher income were the cost driving factors. The socioeconomic impact on the family decreased at follow up probably due to joint family system.

Cited by 19 publications

References 0 publications

The economic impact of non-communicable diseases among households in South Asia and their coping strategy: A systematic review

The economic impact of non-communicable diseases among households in South Asia and their coping strategy: A systematic review

Costs of Hospital Care for Strokes in India: A Scoping Review

Cost-effectiveness of interventions to control cardiovascular diseases and type 2 diabetes mellitus in South Asia: protocol for a systematic review

Contact Info

Product

Resources

About